| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Absence of efficacy of thalidomide monotherapy in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma)
|
Troch, M.
|
|
|
20 |
8 |
p. 1446-1447
|
article
|
| 2 |
A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia
|
Kanai, M.
|
|
|
20 |
8 |
p. 1397-1401
|
article
|
| 3 |
Aloe-induced hypokalemia in a patient with breast cancer during chemotherapy
|
Baretta, Z.
|
|
|
20 |
8 |
p. 1445-1446
|
article
|
| 4 |
A multicenter cohort study to compare quality of life in breast cancer patients according to sentinel lymph node biopsy or axillary lymph node dissection
|
Dabakuyo, T.S.
|
|
|
20 |
8 |
p. 1352-1361
|
article
|
| 5 |
Annals of Oncology: some modest proposals but some great aims
|
Vermorken, Jan B.
|
|
|
20 |
8 |
p. 1289-1290
|
article
|
| 6 |
Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes
|
Breivik, H.
|
|
|
20 |
8 |
p. 1420-1433
|
article
|
| 7 |
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas
|
Hohaus, S.
|
|
|
20 |
8 |
p. 1408-1413
|
article
|
| 8 |
Class III β-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma
|
Koh, Y.
|
|
|
20 |
8 |
p. 1414-1419
|
article
|
| 9 |
Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma
|
Lee, J.O.
|
|
|
20 |
8 |
p. 1402-1407
|
article
|
| 10 |
Comparison of breast density in the contralateral normal breast of patients with invasive and in situ breast cancer measured on MRI
|
Chen, J.-H.
|
|
|
20 |
8 |
p. 1449-1450
|
article
|
| 11 |
‘Cure’ from breast cancer among two populations of women followed for 23 years after diagnosis
|
Woods, L.M.
|
|
|
20 |
8 |
p. 1331-1336
|
article
|
| 12 |
Cure from breast cancer, not quite yet but getting there?
|
Singhal, M.K.
|
|
|
20 |
8 |
p. 1291-1292
|
article
|
| 13 |
Does breast density show difference in patients with estrogen receptor-positive and estrogen receptor-negative breast cancer measured on MRI?
|
Chen, J.-H.
|
|
|
20 |
8 |
p. 1447-1449
|
article
|
| 14 |
Editorial Board
|
|
|
|
20 |
8 |
p. ii-iii
|
article
|
| 15 |
Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I–II study
|
Laurent, S.
|
|
|
20 |
8 |
p. 1369-1374
|
article
|
| 16 |
FOLFOX in patients with metastatic colorectal cancer and high alkaline phosphatase level: an exploratory cohort of the GERCOR OPTIMOX1 study
|
Chibaudel, B.
|
|
|
20 |
8 |
p. 1383-1386
|
article
|
| 17 |
HDAC inhibitor-based therapies and haematological malignancy
|
Stimson, L.
|
|
|
20 |
8 |
p. 1293-1302
|
article
|
| 18 |
in this issue
|
|
|
|
20 |
8 |
p. 1287
|
article
|
| 19 |
Macronutrients, fatty acids and cholesterol intake and stomach cancer risk
|
Lucenteforte, E.
|
|
|
20 |
8 |
p. 1434-1438
|
article
|
| 20 |
Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective
|
Tirelli, U.
|
|
|
20 |
8 |
p. 1445
|
article
|
| 21 |
Optimising treatment regimens for the management of advanced gastric cancer
|
|
|
|
20 |
8 |
p. 1451
|
article
|
| 22 |
Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review
|
Le Scodan, R.
|
|
|
20 |
8 |
p. 1387-1396
|
article
|
| 23 |
Radiological tumor size decrease at week 6 is a potent predictor of outcome in chemorefractory metastatic colorectal cancer treated with cetuximab (BOND trial)
|
Piessevaux, H.
|
|
|
20 |
8 |
p. 1375-1382
|
article
|
| 24 |
Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study
|
Mountzios, G.
|
|
|
20 |
8 |
p. 1362-1368
|
article
|
| 25 |
Table of Contents
|
|
|
|
20 |
8 |
p. iv-v
|
article
|
| 26 |
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up
|
Colleoni, M.
|
|
|
20 |
8 |
p. 1344-1351
|
article
|
| 27 |
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
|
Terpos, E.
|
|
|
20 |
8 |
p. 1303-1317
|
article
|
| 28 |
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
|
Goldhirsch, A.
|
|
|
20 |
8 |
p. 1319-1329
|
article
|
| 29 |
Tissue microarray-based study of patients with lymph node-negative breast cancer shows that HER2/neu overexpression is an important predictive marker of poor prognosis
|
Choi, Y.H.
|
|
|
20 |
8 |
p. 1337-1343
|
article
|
| 30 |
Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series
|
Grosso, F.
|
|
|
20 |
8 |
p. 1439-1444
|
article
|
Journal description